Fexinidazole, the first all-oral treatment for sleeping sickness, approved in DRC
PARIS and GENEVA - January 30, 2019 - Marketing authorization of fexinidazole for the treatment of Trypanosoma brucei gambiense human African trypanosomiasis (HAT), more commonly...



